Protara Therapeutics, Inc. (TARA) stock
TARANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.34+0.02 (+0.86%)
Close on Nov 18, 2026Market cap $138.28MP/E –Yield –
Protara Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2014 it was $2.95M.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $2.95M | – |
See a number that looks wrong?